Squarepoint
PRCT icon

Squarepoint’s Procept Biorobotics PRCT Stock Holding History

Squarepoint’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-191,581
Closed -$6.03M – 4816
2025
Q4 		$6.03M Buy
+191,581
New +$6.35M 0.01% 1341
2025
Q3 		– Sell
-159,600
Closed -$7.29M – 4857
2025
Q2 		$9.19M Sell
159,600
-61,669
-28% -$3.49M 0.01% 1112
2025
Q1 		$12.9M Buy
221,269
+129,494
+141% +$8.84M 0.02% 904
2024
Q4 		$7.39M Buy
91,775
+15,484
+20% +$1.32M 0.01% 1338
2024
Q3 		$6.11M Buy
76,291
+29,818
+64% +$2.12M 0.01% 1277
2024
Q2 		$2.84M Buy
46,473
+12,077
+35% +$718K ﹤0.01% 1788
2024
Q1 		$1.7M Buy
34,396
+27,531
+401% +$1.31M ﹤0.01% 2194
2023
Q4 		$288K Sell
6,865
-22,517
-77% -$767K ﹤0.01% 3390
2023
Q3 		$964K Buy
+29,382
New +$1M ﹤0.01% 2344
2023
Q2 		– Sell
-52,746
Closed -$1.5M – 3910
2023
Q1 		$1.5M Buy
52,746
+25,980
+97% +$916K 0.01% 1615
2022
Q4 		$1.11M Buy
+26,766
New +$1.15M ﹤0.01% 1748
2021
Q4 		– Sell
-26,549
Closed -$1.01M – 3449
2021
Q3 		$1.01M Buy
+26,549
New +$1.02M ﹤0.01% 1556

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Squarepoint's PRCT Position: Q1 2026 in Review

Squarepoint sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 191,581 shares — an estimated $6.03M sold.

Squarepoint first reported a position in PRCT in Q3 2021 and held it in 12 quarters. The position peaked at $12.9M in Q1 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Squarepoint reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 191,581 Procept Biorobotics shares in Q1 2026, an estimated $6.03M.
  • Squarepoint first reported a position in Procept Biorobotics in Q3 2021 and held it in 12 quarters.
  • Squarepoint's Procept Biorobotics position peaked at $12.9M in Q1 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.